143 related articles for article (PubMed ID: 23072213)
1. Discovery of 3-cyclopropylmethyl-7-(4-phenylpiperidin-1-yl)-8-trifluoromethyl[1,2,4]triazolo[4,3-a]pyridine (JNJ-42153605): a positive allosteric modulator of the metabotropic glutamate 2 receptor.
Cid JM; Tresadern G; Vega JA; de Lucas AI; Matesanz E; Iturrino L; Linares ML; Garcia A; Andrés JI; Macdonald GJ; Oehlrich D; Lavreysen H; Megens A; Ahnaou A; Drinkenburg W; Mackie C; Pype S; Gallacher D; Trabanco AA
J Med Chem; 2012 Oct; 55(20):8770-89. PubMed ID: 23072213
[TBL] [Abstract][Full Text] [Related]
2. Discovery of 1-butyl-3-chloro-4-(4-phenyl-1-piperidinyl)-(1H)-pyridone (JNJ-40411813): a novel positive allosteric modulator of the metabotropic glutamate 2 receptor.
Cid JM; Tresadern G; Duvey G; Lütjens R; Finn T; Rocher JP; Poli S; Vega JA; de Lucas AI; Matesanz E; Linares ML; Andrés JI; Alcazar J; Alonso JM; Macdonald GJ; Oehlrich D; Lavreysen H; Ahnaou A; Drinkenburg W; Mackie C; Pype S; Gallacher D; Trabanco AA
J Med Chem; 2014 Aug; 57(15):6495-512. PubMed ID: 25032784
[TBL] [Abstract][Full Text] [Related]
3. Imidazo[1,2-a]pyridines: orally active positive allosteric modulators of the metabotropic glutamate 2 receptor.
Trabanco AA; Tresadern G; Macdonald GJ; Vega JA; de Lucas AI; Matesanz E; García A; Linares ML; Alonso de Diego SA; Alonso JM; Oehlrich D; Ahnaou A; Drinkenburg W; Mackie C; Andrés JI; Lavreysen H; Cid JM
J Med Chem; 2012 Mar; 55(6):2688-701. PubMed ID: 22352782
[TBL] [Abstract][Full Text] [Related]
4. Discovery of 1,4-disubstituted 3-cyano-2-pyridones: a new class of positive allosteric modulators of the metabotropic glutamate 2 receptor.
Cid JM; Duvey G; Tresadern G; Nhem V; Furnari R; Cluzeau P; Vega JA; de Lucas AI; Matesanz E; Alonso JM; Linares ML; Andrés JI; Poli SM; Lutjens R; Himogai H; Rocher JP; Macdonald GJ; Oehlrich D; Lavreysen H; Ahnaou A; Drinkenburg W; Mackie C; Trabanco AA
J Med Chem; 2012 Mar; 55(5):2388-405. PubMed ID: 22364337
[TBL] [Abstract][Full Text] [Related]
5. mGlu2 Receptor Agonism, but Not Positive Allosteric Modulation, Elicits Rapid Tolerance towards Their Primary Efficacy on Sleep Measures in Rats.
Ahnaou A; Lavreysen H; Tresadern G; Cid JM; Drinkenburg WH
PLoS One; 2015; 10(12):e0144017. PubMed ID: 26658273
[TBL] [Abstract][Full Text] [Related]
6. Discovery of 8-Trifluoromethyl-3-cyclopropylmethyl-7-[(4-(2,4-difluorophenyl)-1-piperazinyl)methyl]-1,2,4-triazolo[4,3-a]pyridine (JNJ-46356479), a Selective and Orally Bioavailable mGlu2 Receptor Positive Allosteric Modulator (PAM).
Cid JM; Tresadern G; Vega JA; de Lucas AI; Del Cerro A; Matesanz E; Linares ML; García A; Iturrino L; Pérez-Benito L; Macdonald GJ; Oehlrich D; Lavreysen H; Peeters L; Ceusters M; Ahnaou A; Drinkenburg W; Mackie C; Somers M; Trabanco AA
J Med Chem; 2016 Sep; 59(18):8495-507. PubMed ID: 27579727
[TBL] [Abstract][Full Text] [Related]
7. Pharmacological characterization of JNJ-40068782, a new potent, selective, and systemically active positive allosteric modulator of the mGlu2 receptor and its radioligand [3H]JNJ-40068782.
Lavreysen H; Langlois X; Ahnaou A; Drinkenburg W; te Riele P; Biesmans I; Van der Linden I; Peeters L; Megens A; Wintmolders C; Cid JM; Trabanco AA; Andrés JI; Dautzenberg FM; Lütjens R; Macdonald G; Atack JR
J Pharmacol Exp Ther; 2013 Sep; 346(3):514-27. PubMed ID: 23766542
[TBL] [Abstract][Full Text] [Related]
8. Antipsychotic profiles of TASP0443294, a novel and orally active positive allosteric modulator of metabotropic glutamate 2 receptor.
Hikichi H; Hiyoshi T; Marumo T; Tomishima Y; Kaku A; Iida I; Urabe H; Tamita T; Yasuhara A; Karasawa J; Chaki S
J Pharmacol Sci; 2015 Mar; 127(3):352-61. PubMed ID: 25837934
[TBL] [Abstract][Full Text] [Related]
9. mGlu(2) receptor-mediated modulation of conditioned avoidance behavior in rats.
Megens AA; Hendrickx HM; Hens KA; Talloen WJ; Lavreysen H
Eur J Pharmacol; 2014 Mar; 727():130-9. PubMed ID: 24486391
[TBL] [Abstract][Full Text] [Related]
10. The [18F]FDG μPET readout of a brain activation model to evaluate the metabotropic glutamate receptor 2 positive allosteric modulator JNJ-42153605.
Wyckhuys T; Wyffels L; Langlois X; Schmidt M; Stroobants S; Staelens S
J Pharmacol Exp Ther; 2014 Aug; 350(2):375-86. PubMed ID: 24898267
[TBL] [Abstract][Full Text] [Related]
11. Tricyclic thiazolopyrazole derivatives as metabotropic glutamate receptor 4 positive allosteric modulators.
Hong SP; Liu KG; Ma G; Sabio M; Uberti MA; Bacolod MD; Peterson J; Zou ZZ; Robichaud AJ; Doller D
J Med Chem; 2011 Jul; 54(14):5070-81. PubMed ID: 21688779
[TBL] [Abstract][Full Text] [Related]
12. 1-[(1-methyl-1H-imidazol-2-yl)methyl]-4-phenylpiperidines as mGluR2 positive allosteric modulators for the treatment of psychosis.
Zhang L; Brodney MA; Candler J; Doran AC; Duplantier AJ; Efremov IV; Evrard E; Kraus K; Ganong AH; Haas JA; Hanks AN; Jenza K; Lazzaro JT; Maklad N; McCarthy SA; Qian W; Rogers BN; Rottas MD; Schmidt CJ; Siuciak JA; Tingley FD; Zhang AQ
J Med Chem; 2011 Mar; 54(6):1724-39. PubMed ID: 21366332
[TBL] [Abstract][Full Text] [Related]
13. Translational neurophysiological markers for activity of the metabotropic glutamate receptor (mGluR2) modulator JNJ-40411813: Sleep EEG correlates in rodents and healthy men.
Ahnaou A; de Boer P; Lavreysen H; Huysmans H; Sinha V; Raeymaekers L; Van De Casteele T; Cid JM; Van Nueten L; Macdonald GJ; Kemp JA; Drinkenburg WH
Neuropharmacology; 2016 Apr; 103():290-305. PubMed ID: 26686390
[TBL] [Abstract][Full Text] [Related]
14. Discovery of 5-aryl-1,3-dihydro-2H-imidazo[4,5-b]pyridin-2-ones as positive allosteric modulators of metabotropic glutamate subtype-2 (mGlu2) receptors with efficacy in a preclinical model of psychosis.
Layton ME; Reif AJ; Hartingh TJ; Rodzinak K; Dudkin V; Wang C; Arrington K; Kelly MJ; Garbaccio RM; O'Brien JA; Magliaro BC; Uslaner JM; Huszar SL; Fillgrove KL; Tang C; Kuo Y; Jacobson MA
Bioorg Med Chem Lett; 2016 Feb; 26(4):1260-4. PubMed ID: 26810316
[TBL] [Abstract][Full Text] [Related]
15. Discovery and Kinetic Profiling of 7-Aryl-1,2,4-triazolo[4,3-a]pyridines: Positive Allosteric Modulators of the Metabotropic Glutamate Receptor 2.
Doornbos MLJ; Cid JM; Haubrich J; Nunes A; van de Sande JW; Vermond SC; Mulder-Krieger T; Trabanco AA; Ahnaou A; Drinkenburg WH; Lavreysen H; Heitman LH; IJzerman AP; Tresadern G
J Med Chem; 2017 Aug; 60(15):6704-6720. PubMed ID: 28704052
[TBL] [Abstract][Full Text] [Related]
16. Modulation of group II metabotropic glutamate receptor (mGlu2) elicits common changes in rat and mice sleep-wake architecture.
Ahnaou A; Dautzenberg FM; Geys H; Imogai H; Gibelin A; Moechars D; Steckler T; Drinkenburg WH
Eur J Pharmacol; 2009 Jan; 603(1-3):62-72. PubMed ID: 19046965
[TBL] [Abstract][Full Text] [Related]
17. Comparative analysis of the neurophysiological profile of group II metabotropic glutamate receptor activators and diazepam: effects on hippocampal and cortical EEG patterns in rats.
Siok CJ; Cogan SM; Shifflett LB; Doran AC; Kocsis B; Hajós M
Neuropharmacology; 2012 Jan; 62(1):226-36. PubMed ID: 21791219
[TBL] [Abstract][Full Text] [Related]
18. Preclinical evaluation of the antipsychotic potential of the mGlu2-positive allosteric modulator JNJ-40411813.
Lavreysen H; Langlois X; Donck LV; Nuñez JM; Pype S; Lütjens R; Megens A
Pharmacol Res Perspect; 2015 Mar; 3(2):e00097. PubMed ID: 25692027
[TBL] [Abstract][Full Text] [Related]
19. Preclinical profile of a novel metabotropic glutamate receptor 5 positive allosteric modulator.
Spear N; Gadient RA; Wilkins DE; Do M; Smith JS; Zeller KL; Schroeder P; Zhang M; Arora J; Chhajlani V
Eur J Pharmacol; 2011 Jun; 659(2-3):146-54. PubMed ID: 21335002
[TBL] [Abstract][Full Text] [Related]
20. Neurophysiologic and antipsychotic profiles of TASP0433864, a novel positive allosteric modulator of metabotropic glutamate 2 receptor.
Hiyoshi T; Marumo T; Hikichi H; Tomishima Y; Urabe H; Tamita T; Iida I; Yasuhara A; Karasawa J; Chaki S
J Pharmacol Exp Ther; 2014 Dec; 351(3):642-53. PubMed ID: 25277141
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
